V体育官网入口 - Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia
- PMID: 20302960
- PMCID: PMC2904410
- DOI: "V体育官网" 10.1016/j.bbmt.2010.03.009
Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia
"V体育官网" Abstract
Reduced-intensity conditioning regimens have been used extensively in adults with hematologic malignancies. To address whether this is a feasible approach for children with acute lymphoblastic leukemia, we evaluated transplant outcomes in 38 recipients transplanted from 1995-2005 for whom this was their first transplant. The median age at transplant was 12 years, and 47% had performance scores <90%. Disease status was first complete remission (CR) in 13%, > or =CR2 in 60% of patients, and 22% had active disease at transplantation. Matched related donors were available for a third of patients, about half of whom received bone marrow (BM) and the others, peripheral blood progenitor cells. Sixty percent of unrelated donor transplant recipients received peripheral blood progenitor cells. The day-100 probability of grade II-IV acute graft-versus-host disease was 37% and the 3-year probability of chronic graft-versus-host disease, 26% VSports手机版. At 3 years, the probability of treatment-related mortality was 40%, relapse 37%, and disease-free survival 30%. These data indicate long-term DFS can be achieved using reduced-intensity conditioning regimens in children with acute lymphoblastic leukemia. Given the relatively small cohort, these findings must be validated in a larger population. .
Copyright (c) 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved. V体育安卓版.
Figures
Comment in
-
Reduced-intensity allografting in childhood acute lymphoblastic leukemia. (VSports在线直播)Biol Blood Marrow Transplant. 2011 Mar;17(3):439-40. doi: 10.1016/j.bbmt.2010.12.696. Epub 2010 Dec 21. Biol Blood Marrow Transplant. 2011. PMID: 21172448 No abstract available.
References
-
- Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–178. - PubMed
-
- Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review. Biol Blood Marrow Transplant. 2005;11:823–861. - PubMed
-
- Alousi A, de Lima M. Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Clin Adv Hematol Oncol. 2007;5:560–570. - PubMed
-
- Collins RH, Jr, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997;15:433–444. - PubMed
-
- Elmaagacli AH, Beelen DW, Trenn G, Schmidt O, Nahler M, Schaefer UW. Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1999;23:771–777. - PubMed
"VSports app下载" Publication types
MeSH terms
- "VSports" Actions
- Actions (VSports最新版本)
- V体育ios版 - Actions
- Actions (VSports最新版本)
"VSports app下载" Grants and funding
V体育官网入口 - LinkOut - more resources
"V体育官网入口" Full Text Sources
